News and Press Releases

New Real-World Data Published in Journal of Cardiac Failure on Effectiveness of VYNDAQEL (tafamidis) in Patients with Transthyretin Cardiac Amyloidosis

Patients treated with tafamidis were associated with greater rates of survival compared with patients untreated with tafamidis. 6 August 2024 -- Walton Oaks, UK -- Pfizer Ltd today announced publication...

Category: Drug Discovery, Other, Pharmaceutical
Posted: August 8, 2024

235 East 42nd Street NY, NY 10017

Evotec and Pfizer collaborate to advance drug discovery in France

Multi-year collaboration will initially focus on early discovery research for metabolic and infectious diseases 11 July 2024, Hamburg, Germany – Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:...

Category: Drug Discovery
Posted: July 11, 2024

Just – Evotec Biologics, Inc. 401 Terry Avenue North Seattle, WA 98109, US

Just – Evotec Biologics selected by US Department of Defence for Manufacturing Optimisation Programme

Just – Evotec Biologics will deliver an ultra-rapid, cost-efficient biotherapeutics manufacturing platform solution for the DOD’s manufacturing optimisation programme Manufacturing solution includes seamless integration of accelerated mAb drug development into...

Category: BioManufacturing
Posted: July 10, 2024

Just – Evotec Biologics, Inc. 401 Terry Avenue North Seattle, WA 98109, US

Enterprise Therapeutics publishes preclinical profile of ETD001, a novel inhaled ENaC blocker

Low doses of ETD001 demonstrate exceptionally long duration of action in sheep model of airway mucus clearance Report in Journal of Cystic Fibrosis discloses best-in-class profile of ETD001 ETD001 scheduled...

Category: Biotechnology, Clinical Trials, Drug Delivery, Drug Discovery, Pharmaceutical
Posted: June 12, 2024

Sussex Innovation Centre, University of Sussex, Science Park Square, Falmer, Brighton, BN1 9SB, UK

Oxford Drug Design and CRUK Scotland Institute awarded MRC grant funding to advance novel cancer therapeutics discovery

Collaboration to use genetically engineered mouse models to validate a new approach to cancer therapy 4 June 2024 - United Kingdom - The CRUK (Cancer Research UK) Scotland Institute and Oxford...

Category: Drug Discovery
Posted: June 10, 2024

Oxford Drug Design Lt,d Oxford Centre for Innovation, New Road, Oxford, OX1 1BY, UK

Asymchem Secures Former Pfizer Sandwich, UK, Development and API Pilot Plant Manufacturing Facilities

21 May 2024 -- Teda Tianjin, P R China -- Asymchem Laboratories announced today that it will operate the former Pfizer UK small molecule API pilot plant and part of...

Category: BioManufacturing, Pharmaceutical
Posted: May 21, 2024

Asymchem Laboratories (Tianjin) Co., Ltd No. 6 Dongting 3rd Avenue, TEDA Tianjin, 300457, P.R. China

Sartorius to Advance Drug Discovery and Manufacturing with AI in Collaboration with NVIDIA

Exploring advanced technologies to help bring novel therapies to patients faster Sartorius to leverage NVIDIA solutions used in live-cell imaging platforms in drug discovery, predictive design of manufacturing processes and...

Category: Biotechnology, Drug Discovery
Posted: May 16, 2024

Sartorius Corporation, Otto-Brenner-Straße 20, 37079 Goettingen, Germany

How the Birmingham Drug Discovery Hub created an investment-ready ‘drug library’

18 April 2024 -- Birmingham, UK -- A novel approach to drug discovery is enabling University of Birmingham, UK, researchers to overcome the ‘valley of death’, where projects fail due...

Category: Drug Discovery
Posted: April 18, 2024

Edgbaston Birmingham, B15 2TT

Headlands Research Announces Fifth Research Site under Partnership with Pfizer to Improve Diversity in Clinical Trials

Headlands Research Orlando satisfies the organisations’ commitment to create multiple research sites aimed at increasing health equity in clinical research 28 March 2024 -- California, US -- Headlands Research, a...

Category: Clinical Trials
Posted: April 2, 2024

130 John F Kennedy Dr STE 203 Lake Worth, FL 33462

X‑Chem Adds Chief Technology Officer to Bolster Its Digital Drug Discovery Strategy 

2 April 2024 -- Massachusetts, US -- X-Chem, the leading provider of innovative solutions in early-stage drug discovery, today announced the addition of Dr Erin Davis as chief technology officer....

Category: Drug Discovery
Posted: April 2, 2024

100 Beaver Street Waltham, MA 02453

Semarion introduces SemaCyte Multiplexing Platform to enhance cell assay data quality and speed during drug discovery

Expansion to SemaCyte Microcarrier platform enables optical barcoding and pooling of adherent cells to augment drug discovery high-content imaging and other screening processes Access available through Semarion’s Early Adopter Programme....

Category: Drug Discovery
Posted: March 20, 2024

Cavendish Laboratories JJ Thomson Ave Cambridge CB3 0HE UK

Ubiquigent enters agreement with Astellas subsidiary, Nanna Therapeutics

Agreement leverages Ubiquigent’s DUB-focused drug discovery platform to support the development of novel therapeutic candidates for multiple disease targets selected by Nanna Therapeutics 11 March 2024 -- Dundee, UK --...

Category: Drug Discovery
Posted: March 11, 2024

University Incubator Dundee Technopole James Lindsay Place Dundee DD1 5JJ Scotland, UK

Aston University and University of Warwick team wins £1.8m for research to aid drug discovery and sustainable chemical production

The team will engineer cells to make membrane proteins efficiently The proteins will be used for drug discovery and screening, and as catalysts in sustainable chemical production The £1.8m Engineering...

Category: Drug Discovery
Posted: February 12, 2024

Aston University Birmingham B4 7ET UK